Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1–161) in experimental venous thrombosis--a comparison with low molecular weight heparin - Holst, J; Lindblad, B; Bergqvist, D (Thromb Haemost, 1994)
et al.